Table 2 Comparison of Clinical Data between the AMI Group & stable CAD Group
Categories of Data | The AMI Group | The stable CAD Group | t/x2/z | P Value |
|---|---|---|---|---|
N = 91 | N = 87 |  |  | |
Age (years old) | 63.51 ± 10.506 | 61.9 ± 9.077 | 1.095 | 0.275 |
Sex | Â | Â | 1.185 | 0.276 |
 Male | 59(64.8%) | 63(72.4%) |  |  |
 Female | 32(35.2%) | 24(27.6%) |  |  |
BMI (Kg/m2) | 24.728(22.477–27.357) | 25.626 ± 3.188 | −1.711 | 0.087 |
Hypertension | 46(50.5%) | 44(50.6%) | 0.000 | 0.997 |
Family Medical History | 7(7.7%) | 4(4.6%) | 0.718 | 0.397 |
Systolic Pressure (mmHg) | 135.08 ± 24.740 | 136.38 ± 20.213 | −0.350 | 0.727 |
Diastolic Pressure (mmHg) | 81(75.750–91) | 81.07 ± 12.472 | −1.136 | 0.256 |
Smoking History | 42(46.2%) | 43(49.4%) | 0.191 | 0.662 |
Diabetes | 24(26.4%) | 24(27.6%) | 0.033 | 0.855 |
Fasting Blood-glucose (mmol/l) | 6.03(5.085–8.235) | 5.81(5.240–8.170) | −0.356 | 0.722 |
TG (mmol/l) | 1.57(1.16–2.303) | 1.74(1.14–2.5) | −0.856 | 0.392 |
HDL-C (mmol/l) | 0.96(0.085–1.133) | 0.88(0.770–1.070) | −1.901 | 0.057 |
TC (mmol/l) | 4.616 ± 1.300 | 4.213 ± 1.048 | 2.233 | 0.027 |
LDL-C (mmol/l) | 3.136 ± 1.047 | 2.770 ± 0.877 | 2.480 | 0.014 |
EF(%) | 63(42–65) | 65(63–67.25) | −3.482 | 0.000 |
Aspirin | 87(95.6%) | 85(97.7%) | −0.773 | 0.440 |
Clopidogrel | 78(85.7%) | 77(88.5%) | −0.553 | 0.580 |
Ticagrelor | 1(1.1%) | 2(2.3%) | −0.620 | 0.535 |
Beta blockers | 55(60.4%) | 45(51.7%) | −1.168 | 0.243 |
CCB | 25(27.5%) | 27(31.0%) | −0.521 | 0.602 |
ACE-I or ARB | 47(51.6%) | 30(34.5%) | −2.304 | 0.021 |
Statin | 73(80.2%) | 75(86.2%) | −1.064 | 0.287 |
PCI | 76(83.5%) | 53(60.9%) | −2.593 | 0.010 |